Zivo Bioscience, Inc.·4

Aug 31, 4:12 PM ET

Marchiando Keith 4

4 · Zivo Bioscience, Inc. · Filed Aug 31, 2022

Insider Transaction Report

Form 4
Period: 2022-08-29
Marchiando Keith
Chief Financial Officer
Transactions
  • Award

    Nonstatutory Stock Option to Purchase Common Stock

    2022-08-29+62,00062,000 total
    Exercise: $3.94Exp: 2022-08-28Common Stock (62,000 underlying)
Footnotes (1)
  • [F1]The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.

Documents

1 file
  • 4
    section16.xmlPrimary

    PRIMARY DOCUMENT